Prevalence of Shiga toxin-producing Escherichia coli (STEC) in Tasmania, Australia

Pathology

Volumn 45, Issue 7, 2013, Pages 681-688

  McCallum, Corrine ^a   McGregor, Alistair ^a   Vanniasinkam, Thiru ^b  

^a ROYAL HOBART HOSPITAL   (Australia)

^b CHARLES STURT UNIVERSITY   (Australia)

Author keywords

CHROMagar; CT SMAC; Prevalence; Shiga Toxin producing Escherichia coli; STEC; STEC Screening Easy Plex MT PCR; Tasmania

Indexed keywords

ARTICLE; AUSTRALIA; ENTERITIS; ESCHERICHIA COLI INFECTION; FECES; HUMAN; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIOLOGY; SENSITIVITY AND SPECIFICITY; SHIGA TOXIN PRODUCING ESCHERICHIA COLI;

ENTERITIS; ESCHERICHIA COLI INFECTIONS; FECES; HUMANS; INCIDENCE; SENSITIVITY AND SPECIFICITY; SHIGA-TOXIGENIC ESCHERICHIA COLI; TASMANIA;

EID: 84896795595     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0000000000000000     Document Type: Article

References (62)

1. McPherson M, Lalor K, Combs B., et al Serogroup-specific risk factors for Shiga toxin-producing Escherichia coli infection in Australia. Clin Infect Dis 2009; 49: 249-56.
2. Gould L, Bopp C, Strockbine N., Atkinson R, et al Recommendations for diagnosis of Shiga toxin-producing Escherichia coli infections by clinical laboratories. MMWR Recomm Rep 2009; 58 (RR12): 1-4.
3. Gould D. Causes, prevention and treatment of Escherichia coli infections. Nurs Stand 2010; 24: 50-6.
4. Thorpe CM. Shiga toxin-producing Escherichia coli infection. Clin Infect Dis 2004; 38: 1298-303.
5. Pollock KGJ, Stewart A, Beattie T.J., et al From diarrhoea to haemolytic uraemic syndrome - when to seek advice. J Med Microbiol 2009; 58: 397-8.
6. Gould LH, Demma L, Jones T.F., et al Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, Foodborne Diseases Active Surveillance Network Sites, 2000-2006. Clin Infect Dis 2009; 49: 1480-5.
7. Barlow RS, Gobius KS, Desmarchelier PM Shiga toxin-producing Escherichia coli in ground beef and lamb cuts: Results of a one-year study. Int J Food Microbiol 2006; 111: 1-5.
8. Voetsch A, Kennedy MH, Keene W.E., et al Risk factors for sporadic Shiga toxin-producing Escherichia coli O157 infections in Foodnet sites, 1999-2000. Epidemiol Infect 2007; 135: 993-1000.
9. Lienemann T, Pitkänen T, Antikainen J., et al Shiga toxin-producing Escherichia coli O100:H: stx in drinking water contaminated by waste water in Finland. Curr Microbiol 2011; 62: 1239-44.
10. Hanna J, Humphreys JL, Ashton S.E., et al Haemolytic uraemic syndrome associated with a family cluster of enterohaemorrhagic Escherichia coli. Commun Dis Intell 2007; 31: 300-3.
11. Werber D, Mason BW, Evans M.R., et al Preventing household transmission of Shiga toxin-producing Escherichia coli O157 infection: promptly separating siblings might be the key. Clin Infect Dis 2008; 46: 1189-96.
12. Beutin L, Krause G, Zimmermann S., et al Characterization of Shiga toxin-producing Escherichia coli strains isolated from human patients in Germany over a 3-year period. J Clin Microbiol 2004; 42: 1099-108.
13. Leotta G, Miliwebsky E, Chinen I., et al Characterisation of Shiga toxin-producing Escherichia coli O157 strains isolated from humans in Argentina, Australia and New Zealand. BMC Microbiol 2008; 8: 46.
14. Johnson KE, Thorpe CM, Sears CL The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. Clin Infect Dis 2006; 43: 1587-95.
15. Brooks JT, Sowers EG, Wells J.G., et al Non-O157 Shiga Toxin-Producing Escherichia coli Infections in the United States, 1983-2002. J Infect Dis 2005; 192: 1422-9.
16. Frank C, Werber D, Cramer J.P., et al Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. N Engl J Med 2011; 365: 1771-80.
17. Vally H, Hall G, Dyda A., et al Epidemiology of Shiga toxin producing Escherichia coli in Australia, 2000-2010. BMC Public Health 2012; 12: 63.
18. Combs BG, Raupach JCA, Kirk MD Surveillance of Shiga toxigenic Escherichia coli in Australia. Commun Dis Intell 2005; 29: 366-9.
19. Mueller E, Ehlers MM Biolog identification of non-sorbitol fermenting bacteria isolated on E. coli O157 selective CT-SMAC agar. Water SA 2005; 31: 247-52.
20. Bettelheim KA. Reliability of O157:H7 ID agar (O157 H7 ID-F) for the detection and isolation of verocytotoxigenic strains of Escherichia coli belonging to serogroup O157. J Appl Microbiol 2005; 99: 408-10.
21. Church DL, Emshey D, Semeniuk H., et al Evaluation of BBL CHRO-Magar O157 versus sorbitol-MacConkey medium for routine detection of Escherichia coli O157 in a centralized regional clinical microbiology laboratory. J Clin Microbiol 2007; 45: 3098-100.
22. Manandhar R, Bettiol SS, Goldsmid J.M., et al First report of the isolation of Escherichia coli O157: H-in Tasmania. Aust J Med Sci 1995; 16: 39-40.
23. Manandhar R, Bettiol SS, Bettelheim K.A., et al Isolation of verotoxigenic Escherichia coli from the Tasmanian environment. Comp Immunol Micro-biol Infect Dis 1997; 20: 271-9.
24. Fegan N, Vanderlinde P, Higgs G, et al. The prevalence and concentration of Escherichia coli O157 in faeces of cattle from different production systems at slaughter. J Appl Microbiol 2004; 97: 362-70.
25. Stark D, Al-Qassab SE, Barratt JLN, et al Evaluation of multiplex tandem real-time PCR for detection of Cryptosporidium spp., Dientamoeba fragilis, Entamoeba histolytica, and Giardia intestinalis in clinical stool samples. J Clin Microbiol 2011; 49: 257-62.
26. Rice EW, Sowers EG, Johnson C.H., et al Serological cross-reactions between Escherichia coli O157 and other species of the genus Escherichia. J Clin Microbiol 1992; 30: 1315-6.
27. Commonwealth of Australia. STEC(VTEC)/HUS Case Questionnaire: OzFoodNet STEC questionnaire version 1.0, 2012. Cited Nov 2012. http://www.health.nsw.gov. au/resources/publichealth/infectious/diseases/Enteric/pdf/stec-questionnaire- 20110621.pdf
28. Australian Bureau of Statistics. Population by Age and Sex, Regions of Australia, 2011. Cat. no. 3235.0. Canberra: Australian Bureau of Statistics, 2012.
29. Paton AW, Paton JC Direct detection and characterization of Shiga toxigenic Escherichia coli by multiplex PCR for stx1, stx2, eae, ehxA, and saa. J Clin Microbiol 2002; 40: 271-4.
30. Australian Bureau of Statistics. Postcode 2011 to Statistical Area Level 4 2011. In: Australian Statistical Geography Standard (ASGS): Correspondences. 1270.0.55.006. Canberra: Australian Bureau of Statistics, 2012.
31. Hall G, Yohannes K, Raupach J., et al Estimating community incidence of Salmonella, Campylobacter and Shiga toxin-producing Escherichia coli infections, Australia. Emerg Infect Dis 2008; 14: 1601-9.
32. McPherson M, Kirk M, Raupach J., et al Economic costs of Shiga toxin-producing Escherichia coli infection in Australia. Foodborne Pathog Dis 2011; 8: 55-62.
33. Bennett-Wood V.R., Russell J, Bordun A-M, et al Detection of enterohae-morrhagic Escherichia coli in patients attending hospital in Melbourne, Australia. Pathology 2004; 36: 345-51.
34. Doyle R, Watson K, Unicomb L.E., et al Laboratory surveillance of Shiga toxin producing Escherichia coli in South Australia and the Hunter Health Area, New South Wales, Australia. Commun Dis Intell 2004; 28: 390-1.
35. Goldwater PN, Bettelheim KA An outbreak of hemolytic uremic syndrome due to Escherichia coli O157: H-or was it? Emerg Infect Dis 1996; 2: 153-4.
36. European Food Safety Authority. Scientific Report Of EFSA and ECDC: The European Union Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Food-borne Outbreaks in 2010. 11 May 2012. http://www.efsa.europa.eu/en/ efsajournal/pub/2597.htm
37. Hoefer A, Hurd S, Medus C., et al Laboratory practices for the identification of Shiga toxin-producing Escherichia Coli in the United States, Foodnet sites, 2007. Foodborne Pathog Dis 2011; 8: 555-60.
38. Werber D, Behnke SC, Fruth A, et al Shiga Toxin-producing Escherichia coli infection in Germany-Different risk factors for different age groups. Am J Epidemiol 2007; 165: 425-34.
39. Miliwebsky E, Deza N, Chinen I., et al Prolonged fecal shedding of Shiga toxin-producing Escherichia coli among children attending day-care centers in Argentina. Rev Argent Microbiol 2007; 39: 90-2.
40. Tarr PI, Gordon CA, Chandler WL Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005; 365: 1073-86.
41. Zahraei Salehi T., Askari Badouei M, Mehdizadeh Gohari I. Molecular detection and antibacterial susceptibility of enteropathogenic Escherichia coli (EPEC) and shigatoxigenic Escherichia coli(STEC) strains isolated from healthy and diarrhoeic dogs. Comp Clin Pathol 2011; 20: 585-9.
42. Kaper JB. Defining EPEC. Rev Microbiol 1996; 27 (Suppl 1): 130-3.
43. Bielaszewska M, Middendorf B, Köck R, et al Shiga toxin-negative attaching and effacing Escherichia coli: distinct clinical associations with bacterial phylogeny and virulence traits and inferred in-host pathogen evolution. Clin Infect Dis 2008; 47: 208-17.
44. Bielaszewska M, Prager R, Köck R, et al Shiga toxin gene loss and transfer in vitro and in vivo during enterohemorrhagic Escherichia coli O26 infection in humans. Appl Environ Microbiol 2007; 73: 3144-50.
45. Mellmann A, Bielaszewska M, Zimmerhackl L.B., et al Enterohemorrhagic Escherichia coli in human infection: in vivo evolution of a bacterial pathogen. Clin Infect Dis 2005; 41: 785-92.
46. Hornitzky MA, Vanselow BA, Walker K, et al Virulence properties and serotypes of Shiga toxin-producing Escherichia coli from healthy Australian cattle. Appl Environ Microbiol 2002; 68: 6439-45.
47. Park S-H, Ryu S., Kang D-H. Improved selective and differential medium for isolation of Escherichia coli O157:H7. J Clin Microbiol 2011; 49: 405-8.
48. Fujisawa T, Sata S, Aikawa K., et al Modification of sorbitol MacConkey medium containing cefixime and tellurite for isolation of Escherichia coli O157:H7 from radish sprouts. Appl Environ Microbiol 2000; 66: 3117-8.
49. Tzschoppe M, Martin A, Beutin L. A rapid procedure for the detection and isolation of enterohaemorrhagic Escherichia coli (EHEC) serogroup O26, O103, O111, O118, O121, O145 and O157 strains and the aggregative EHEC O104:H4 strain from ready-to-eat vegetables. Int J Food Microbiol 2012; 152: 19-30.
50. Hauswaldt SI, Rodloff AC, Solbach W, et al Improving diagnostics of diarrheagenic Escherichia coli by use of a new chromogenic medium. Cited Nov 2012. http://www.chromagar.com/fichiers/1336122885ECCMID-Poster-STEC-Hauswaldt. pdf?PHPSESSID=2d3ff997d926afc8c9b26be5ee16ca60
51. Orth D, Grif K, Dierich M.P., et al Variability in tellurite resistance and the ter gene cluster among Shiga toxin-producing Escherichia coli isolated from humans, animals and food. Res Microbiol 2007; 158: 105-11.
52. Giercke S, Wylie JL, Van Caesseele P, et al Evaluation of a new chromo-genic agar medium for detection of Shiga toxin-producing Esherichia coli. Cited Nov 2012. http://www.chromagar.com/fichiers/1342019490ST-GIERCKE-WYLIE- ASM-2012.pdf?PHPSESSID=2d3ff997d926afc8c9b26be5ee16ca60
53. Konowalchuk J, Speirs JL, Stavric S. Vero response to a cytotoxin of Escherichia coli. Infect Immun 1977; 18: 775-9.
54. Schuurman T, Roovers A, van der Zwaluw WK, et al. Evaluation of 5'-nuclease and hybridization probe assays for the detection of shiga toxin-producing Escherichia coli in human stools. J Microbiol Methods 2007; 70: 406-15.
55. Ziebell KA, Read SC, Johnson R.P., Gyles CL Evaluation of PCR and PCR-RFLP protocols for identifying Shiga toxins. Res Microbiol 2002; 153: 289-300.
56. Derzelle S, Grine A, Madic J., et al A quantitative PCR assay for the detection and quantification of Shiga toxin-producing Escherichia coli (STEC) in minced beef and dairy products. Int J Food Microbiol 2011; 151: 44-51.
57. Feng PCH, Jinneman K, Scheutz F., et al Specificity of PCR and serological assays in the detection of Escherichia coli Shiga toxin subtypes. Appl Environ Microbiol 2011; 77: 6699-702.
58. Persson S, Olsen KEP, Scheutz F, et al A method for fast and simple detection of major diarrhoeagenic Escherichia coli in the routine diagnostic laboratory. Clin Microbiol Infect 2007; 13: 516-24.
59. van Duynhoven YTHP, Friesema IHM, Schuurman T, et al. Prevalence, characterisation and clinical profiles of Shiga toxin-producing Escherichia coli in The Netherlands. Clin Microbiol Infect 2008; 14: 437-45.
60. Stuart R, Marshall C, McLaws M-L, et al ASID/AICA Position Statement - Infection Control Guidelines for Patients with 'Clostridium difficile' Infection in Healthcare Settings. Healthcare Infect 2011; 16: 33-9.
61. Combs B, Wise RP, Tribe I.G., et al Investigation of two clusters of shiga toxin-producing Escherichia coli cases in South Australia. Commun Dis Intell 2003; 27: 517-9.
62. Reiss G, Kunz P, Koin D., et al Escherichia coli O157:H7 infection in nursing homes: review of literature and report of recent outbreak. J Am Geriatr Soc 2006; 54: 680-4.